1. Home
  2. MIRM vs RIOT Comparison

MIRM vs RIOT Comparison

Compare MIRM & RIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

N/A

Current Price

$86.88

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

N/A

Current Price

$14.31

Market Cap

5.8B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MIRM
RIOT
Founded
2018
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.8B
IPO Year
2019
2002

Fundamental Metrics

Financial Performance
Metric
MIRM
RIOT
Price
$86.88
$14.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
13
Target Price
$114.67
$25.81
AVG Volume (30 Days)
763.1K
15.0M
Earning Date
05-06-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
74.59
N/A
EPS
N/A
N/A
Revenue
$19,138,000.00
$647,435,000.00
Revenue This Year
$26.22
N/A
Revenue Next Year
$21.77
$25.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
71.89
52 Week Low
$36.88
$6.19
52 Week High
$109.28
$23.94

Technical Indicators

Market Signals
Indicator
MIRM
RIOT
Relative Strength Index (RSI) 40.71 46.22
Support Level $85.76 $12.41
Resistance Level $96.65 $15.95
Average True Range (ATR) 3.90 0.99
MACD -0.38 -0.07
Stochastic Oscillator 16.52 36.11

Price Performance

Historical Comparison
MIRM
RIOT

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

Share on Social Networks: